A multicentric, hyaline vascular variant of Castleman's disease associated with B cell lymphoma: a case report by Erkurt, Mehmet Ali et al.
Case report
Open Access
A multicentric, hyaline vascular variant of Castleman’s disease
associated with B cell lymphoma: a case report
Mehmet Ali Erkurt
1*, Ismet Aydogdu
1, Irfan Kuku
1, Emin Kaya
1,
Bulent Mizrak
2 and Yalcın Basaran
3
Addresses:
1Department of Hematology, Inonu University Faculty of Medicine, Malatya-Elazig Street, Malatya, 44069, Turkey,
2Department of
Pathology, Inonu University Faculty of Medicine, Malatya-Elazig Street Malatya, 44069, Turkey and
3Department of Internal Medicine,
Gulhane Military Medical Academy, Tevfik Saglam Street, Ankara, 06010, Turkey
Email: MAE* - erkurtali@hotmail.com; IA - iaydogdu@selcuk.edu.tr; IK - ikuku@inonu.edu.tr; EK - ekaya@inonu.edu.tr;
BM - bmizrak@inonu.edu.tr; YB - yalcinbasaran@hotmail.com
*Corresponding author
Received: 29 August 2008 Accepted: 19 April 2009 Published: 10 June 2009
Cases Journal 2009, 2:8183 doi: 10.4076/1757-1626-2-8183
This article is available from: http://casesjournal.com/casesjournal/article/view/8183
© 2009 Erkurt et al; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: Three histological variants (hyaline vascular, plasma cell, and mixed) and two clinical
types (localized and multicentric) of Castleman’s disease have been described. The risk of progression
to lymphoma is higher in multicentric Castleman’s disease and is associated with poorer outcomes
and higher mortality rate. Multicentric Castleman’s disease often requires systemic therapy.
Complete resection of the involved node in localized Castleman’s disease is curative, with no
reported recurrences.
Case presentation: We report a case of a 66-year-old female with systemic symptoms and bilateral
cervical lymph nodes which were initially diagnosed as the hyaline vascular variant of Castleman’s
disease and two years later after the initial diagnosis she was confirmed to B cell lymphoma. Following
the treatment with radiation therapy to the cervical area and combination chemotherapy complete
response was achieved.
Conclusion: Although it has rarely been reported, the malignant potential of the Castleman’s
disease must be kept in mind.
Introduction
Castleman’s disease (CD) was firstly defined in 1956 as a
mediastinal lymph node hyperplasia consisting of
“regressed” germinal center and capillary “proliferation”.
It may also be named as mediastinal lymph node tumor,
giant lymph node hyperplasia, or angiofollicular lymph
node hyperplasia. The etiopathology is unknown [1]. It is
classified into three major histopathological subtypes:
hyaline vascular variant, plasma cell variant and mixed
type. It may also be categorized clinically as localized
(unicentric) and multicentric types [2]. The hyaline
vascular variant of CD is characterized by a marked
increase of abnormal follicles with athrophic germinal
centers which are poor in terms of follicular cells and rich
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vascular proliferation and hyaline material storage are
observed in this type. On the other hand, the plasma cell
variant of CD has hyperplastic germinal centers. Inter-
follicular zone is characterized by mature plasma cells,
large follicles and rare vascular stroma. 2/3 of the cases are
associated with mediastinal and pulmonary involvement,
while the other 1/3 with extranodal and non-mediastinal
involvement [2,3]. The hyaline vascular variant is seen by
90 percent and the ongoing is mostly asymptomatic.
Approximately 10 percent of all cases are of the plasma cell
variant, while a small percent had a mixed histological
appearance. The plasma cell variant of CD has a more
aggressive behavior compared to the hyaline vascular
variant. 90 percent of the multicentric cases consist of the
plasma cell variant [2]. Multicentric CD is a systemic
disease with generalized peripheral lymphadenopathy,
hepatosplenomegaly, frequent fevers, night sweats, weight
loss, and weakness or fatigue. It is aggressive in behavior
and is usually fatal due to fulminant infections or related
malignancies, particularly Kaposi’s sarcoma and lympho-
mas [4-6]. Localized CD is most often an isolated benign
lymphoproliferative disorder and the vast majority of
cases are of the hyaline vascular variant. It is usually
asymptomatic and is rarely associated with an increased
risk of lymphoma [7]. In this report, we present a rare case
of multicentric, hyaline vascular variant of Castleman’s
disease that transformed to associated with B cell
lymphoma.
Case presentation
We present a case of a 66-year-old Turkish female with the
multicentric, hyaline vascular variant of CD that associated
with diffuse large B cell lymphoma. She applied to our
center in January 2006, with bilateral cervical masses
which have persisted two years since the initial diagnosis
and progressively growed. She had dyspnea and pain due
to the enlarged lymph nodes. She had also a history of
constitutional symptoms such as weight loss and night
sweats. Biopsies had been performed form multiple
cervical nodes. Pathologic examination of the resected
nodes had been reported as reactive lymph node
hyperplasia (Figure 1) and she had been followed up
without any treatment. Her complaints had persisted and
an excisional biopsy of a supraclavicular lymph node had
been obtained in March 2005. Pathologic examination of
the node had been reported as the hyaline vascular variant
of CD. A complete physical examination was performed
at presentation which revealed multiple submandibular,
pre-postauricular, supraclavicular lymphadenopathies.
They were freely movable in the subcutaneous space,
non-tender, rubbery and the biggest one was 3 ¥ 2c mi n
diameter. On examination, there was no ulceration,
retraction, skin dimpling and discharge was not expressed.
Otorhinolaryngologic examination was normal and no
hepatosplenomegaly was detected. There was bilateral
inguinal lymphadenopathy. Cranial nerve examination
was normal. Complete blood count, routine biochemical
tests and Ig G, A, M, kappa, lambda levels were within
normal limits. EBV, HHV8 and HIV serology were
negative. In the bone marrow evaluation (aspiration and
biopsy) no signs of lymphoma involvement were demon-
strated. Bone marrow assessment by flow cytometry
revealed neoplastic cells positive for CD19, CD20,
CD22, CD45 and CD10 and negative for CD2, CD3,
CD5 and CD138. Computed tomographic scan showed
the presence of multiple enlarged lymph nodes of the head
and neck (parotid, submandibular, anterior and posterior
cervical nodes) and cervical lymph node conglomeration
in diameter of 3 ¥ 2 cm, which was narrowing the airway
at the oropharyngeal level Thoracic CT findings consisted
of enlarged, conglomerated mediastinal, prevascular,
paratracheal, bilateral hiler and subcarinal lymph nodes
and a subpleural node, 1 cm in diameter, at the medio-
basal segment of the left lower lobe (Figure 2A,B).
Abdominal computed tomography revealed conglomer-
ated lymphadenopaties in both inguinal areas. The
involved nodes were resected and they were taken under
histopathologic evaluation. Six capsulated lymph nodes
were macroscopically observed, the biggest 3 ¥ 2 cm, and
the smallest 1 ¥ 1 cm in diameter. Microscopic appear-
ance of paraffin sections showed hyperplastic lymph
nodes with atrophic germinal centers. These lymph
nodes had aprominent proliferation of hyalinized follicles
with marked interfollicular vascular proliferation. Some of
the resected nodes were totally ruined. Analysis of cell
surface markers on reactive lymph nodes revealed the lack
of CD30, CD99, CD4, CD8, CD3, CD5, and also the
Figure 1. Hyalinized germinal center surrounded with
mature lymphoid cells. (Hematoxylin & eosin stain; original
magnification x 40).
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Both morphologic and immunophenotypic features sug-
gested us associated with CD to B cell lymphoma. The
patient was classified as having stage 3B disease. When the
diagnosis was established she received radiotherapy (a
total dose of 4000 cGy) to cervical area as initial treatment.
RT was followed by six cycles of CHOP chemotherapy
(Cyclophosphamide 750 mg/m
2/day, Doxorubicin
50 mg/m
2/day, Vincristine 1.4 mg/m
2/day and Prednisone
100 mg/day). Following the treatment with radiotherapy
and aggressive combination chemotherapy a durable
complete response was achieved. The patient is now in
complete remission with a follow-up of 2 years.
Discussion
CD, firstly described by Benjamin Castleman in 1956, is a
lymphoproliferative disorder of unknown etiology [8]. It
is also known as angiomatous lymphoid hamartoma,
giant lymph node hyperplasia, angiofollicular lymph node
hyperplasia or lymphoreticuloma [2,8,9]. The generation
of IL-6 in germinal centers of hyperplastic lymph nodes,
which results in induction of B-cell differentiation, seems
to be implicated in the etiopathogenesis of the disease [4].
Thoracic, cervical, abdominal, and axillary involvements
are reported to be 60, 14, 11, 4 percent, respectively [10].
The outcomes of the hyaline vascular variant of CD
generally remain favorable. Symptoms associated with the
presence of a space-occupying lesion, including cough,
dyspnea, dysphagia, hemopthysis, angina, upper respira-
tory system infections and back pain may be observed [3].
On the other hand, patients with the multicentric, plasma
cell variant of CD present with fever, which is nearly
universal, as well as night sweats, weight loss, weakness or
fatigue and sometimes with polyneuropathies. Addition-
ally, anemia, leucocytosis, hypergammaglobulinemia,
hypoalbuminemia, elevated sedimentation rate and
increased levels of CRP may also be observed [11]. This
case had a two year history of weight loss and night
sweating but routine investigations such as complete
blood count and biochemical profile were found to be
within normal range. It has been shown that there is a
strong association between the multicentric, plasma cell
variant of CD and HHV-8. It is assumed that this virus
increases the risk of extranodal B cell lymphoma and
Kaposi’s sarcoma by inducing the expression of IL-6 which
is found to stimulate vascular endothelial growth factor
expression [2,12]. This case, the serologic tests for HIV and
HHV-8 infections were negative. Imaging techniques may
provide information in identifying and determining the
extent of the lymphadenopathy, but have little impact on
definite diagnosis. The most critical diagnostic test is an
accurate histopathologic evaluation. Immunohistochem-
ical assessment is important in diagnosis. Although the
diagnosis can be suggested by routine radiologic studies
and fine needle aspiration, this case was confirmed with
immunohistochemical assessment of the resected nodes.
The available literature suggests that progression of the
multicentric, variant of CD to B cell lymphoma is more
frequent. Additionally, the progression of hyaline vascular
type of CD to malignant lymphoma is very rare and only
small number of cases has been identified in the literature
[7]. Because of progressive enlargement of the lymph
nodes and the persistence of the systemic symptoms, since
the initial evaluation of the patient, excisional biopsy was
repeated. Histopathologic evaluation of the resected nodes
revealed associated with B cell lymphoma. Prognosis of
CD strongly depends on the precise histologic subtype, the
extent and sites of disease. Mortality rates have been
reported to be more than 50 percent in multicentic CDdue
to infectious complications and related malignancies [9].
The median survival time is 29 months and 26 percent of
the patients die in a year after the initial diagnosis. Surgical
resection is sufficient in the treatment of localized CD, it
generally does not have a role in the treatment of
multicentric CD, and therefore a multidiscipliner
Figure 2. (A) Cervical CT of the patient before the
treatment. (B) Thorax CT of the patient before the
treatment.
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interferon alpha and steroids may be used as treatment
[2,6,13,14]. At admission to our clinic, the patient
presented with night sweats, weight loss and progressively
enlarged cervical lymph nodes within a 2-year period. No
viral infection was detected. It is difficult to establish an
accurate estimate, whether the development of lymphoma
occurred de novo or was secondary to CD in this case.
Although CD was histopathologic confirmed by lymph
node biopsy, we did not perform further immunohisto-
chemical assessment and we do not really know if it was
initially associated with lymphoma. Although receiving
no treatment over a 2-year period until the day before
diagnosis and having less aggressive clinical course, as
usually not expected in patients with lymphoma, it is
highly likely that Multicentric CD associated with lym-
phoma. The incidence of lymphoma is increased in
patients with CD compared with the general population.
In the literature, progression to malignant lymphoma in
Multicentric CD associated with HIV is frequent, and
within a prospective cohort study of 60 HIV-infected
patients with Multicentric CD, and a follow-up period of
20 months, 14 patients (23%) are reported to develop
HHV8-associated non-Hodgkin lymphoma. The five-year
survival rate in Multicentric CD is 82% and this prognosis
appears to be far better than that encountered with
malignant lymphomas. Multicentric CD runs a more
aggressive course and can progress to non-Hodgkin’s
Figure 3. (A) Athropic germinal centers and thick walled vessels in lymphoid follicles Parafollicular areas are enlarged.
(Hematoxylin & eosin stain; original magnification x 4). (B) Immunohistochemically CD20 positive areas 4x.
(C) Immunohistochemically CD20 positive lymphoid malignant cells 40x. (D) A few of malign lymphocytic cells
(Hematoxylin & eosin stain; original magnification x 40).
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associated, is generally treated with combination chemo-
therapy (CHOP) [13,14].
In this case, we assumed malignant lymphoma developed
two years later after the diagnosis of the multicentric,
hyaline vascular variant of CD. Following the treatment
with radiotherapy and combination chemotherapy a
durable complete response was achieved.
Conclusion
The multicentric, hyaline vascular variant of CD has rarely
been reported in the literature. Multicentric CD runs a
more aggressive course and can progress to non-Hodgkin’s
lymhoma. Because of its malignant potential, it must be
kept in mind as a differential diagnosis in the patients with
lymphadenopathic presentations. Follow-up is necessary
to detect the malignant lesions. Prompt recognition and
therapy is critical for these situations, which may be life-
threatening.
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